​

Funding Round

Post-IPO Equity - Celcuity

Post-IPO Equity - Celcuity

Investment Firm

Overview

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Announced Date

May 16, 2022

Closed on Date

Dec 12, 2022

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorCommodore Capital
Participant InvestorSoleus Capital
Participant InvestorBrian Sullivan
Participant InvestorRA Capital Management
Participant InvestorNew Enterprise Associates

Round Details and Background

Celcuity raised $100000000 on 2022-05-16 in Post-IPO Equity

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 30, 2024
Post-IPO Equity - Celcuity
6-60.0M
May 30, 2024
Post-IPO Debt - Celcuity
1-62.0M
Feb 26, 2016
Venture Round - Celcuity
-5.2M
Mar 24, 2014
Series A - Celcuity
1-4.0M

Recent Activity

There is no recent news or activity for this profile.